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SObjective: The study objectivewas to assess in a randomized controlled study (NCT00566839) the comparative
results of awake nonresectional or nonawake resectional lung volume reduction surgery.
Method: Sixty-three patients were randomly assigned by computer to receive unilateral video-assisted thoracic
surgery lung volume reduction surgery by a nonresectional technique performed through epidural anesthesia in
32 awake patients (awake group) or the standard resectional technique performed through general anesthesia in
31 patients (control group). Primary outcomes were hospital stay and changes in forced expiratory volume in 1
second. During follow-up, the need of contralateral treatment because of loss of postoperative benefit was con-
sidered a failure event as death.
Results: Intergroup comparisons (awake vs control) showed no difference in gender, age, and body mass index.
Hospital stay was shorter in the awake group (6 vs 7.5 days, P ¼ .04) with 21 versus 10 patients discharged
within 6 days (P¼ .01). At 6 months, forced expiratory volume in 1 second improved significantly in both study
groups (0.28 vs 0.29 L) with no intergroup difference (P ¼ .79). In both groups, forced expiratory volume in 1
second improvements lasted more than 24 months. At 36 months, freedom from contralateral treatment was
55% versus 50% (P ¼ .5) and survival was 81% versus 87% (P ¼ .5).
Conclusions: In this randomized study, awake nonresectional lung volume reduction surgery resulted in signif-
icantly shorter hospital stay than the nonawake procedure. There were no differences between study groups in
physiologic improvements, freedom from contralateral treatment, and survival. We speculate that compared
with the nonawake procedure, awake lung volume reduction surgery can offer similar clinical benefit but a faster
postoperative recovery. (J Thorac Cardiovasc Surg 2012;143:47-54)Supplemental material is available online.e Departments of Thoracic Surgery,a Pneumology,b Anesthesiology, and In-
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The Journal of Thoracic and CVideo clip is available online.Lung volume reduction surgery (LVRS) is a well-
established, palliative surgical treatment for severe emphy-
sema that has shown to significantly improve pulmonary
function, exercise capacity, quality of life, and survival in
selected patients.1
Highly satisfactory clinical results have been reported by
bilateral LVRS performed through median sternotomy2 and
unilateral or bilateral LVRS performed through video-
assisted thoracic surgery (VATS)3 or thoracotomy.4 Unfor-
tunately, none of these approaches has minimized the
significant morbidity and long hospitalization that are com-
monly associated with this surgical procedure. As a result,
questions have been raised as to the cost-effectiveness of
LVRS, eventually leading to a dramatic reduction in the
number of procedures that are performed yearly.5 In an at-
tempt of avoiding shortcomings of LVRS, novel surgicalardiovascular Surgery c Volume 143, Number 1 47
Abbreviations and Acronyms
FEV1 ¼ forced expiratory volume in 1 second
FVC ¼ forced vital capacity
LVRS ¼ lung volume reduction surgery
PaCO2 ¼ arterial carbon dioxide tension
PaO2/
FIO2
¼ ratio of arterial oxygen tension to
fraction of inspired oxygen
QR ¼ quartile range
RV ¼ residual volume
VATS ¼ video-assisted thoracic surgery
WT ¼ walking test
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Sand endoscopic6 lung volume reduction methods are being
actively investigated.
Because morbidity can be negatively affected by both the
need of general anesthesia and the deep resection of lung
tissue in LVRS, we have developed an awake nonresec-
tional method that respects the basic principles of resec-
tional LVRS but adds theoretic advantages, including the
possibility of being performed through sole thoracic epidu-
ral anesthesia in fully awake patients.
Preliminary findings from our group have suggested that
awake nonresectional LVRS can be easily performed and
optimally tolerated, and can offer clinical improvements
that can be superior to those achieved by the standard resec-
tional method.7 Moreover, in a recent study comparing non-
resectional LVRS performed by awake or nonawake
anesthesia, a shorter hospital stay and reduced costs were
observed in the awake group.8
The current prospective randomized study comparatively
assesses the outcomes of awake nonresectional versus non-
awake resectional LVRS performed by unilateral VATS.MATERIAL AND METHODS
Sixty-three patients undergoing unilateral LVRS byVATS at the Tor Ver-
gata University School of Medicine between December 2002 and October
2006 were randomized to receive awake nonresectional (32 patients, awake
group) or nonawake resectional (31 patients, control group) LVRSbyVATS.
The study was approved by the Tor Vergata ethical committee, and all
patients provided written informed consent. The main characteristics of
the trial have been registered at the ClinicalTrials.gov site (trial No.
NCT00566839).
Inclusion and exclusion criteria entailed findings of severe smoking-
related emphysema with upper-lobe predominance, associated with severe
disability despite maximized medical care and no contraindication for
VATS or thoracic epidural catheterization (Table E1).
Preoperative workup included spirometry with plethysmography, high-
resolution computed tomography of the chest, assessment of arterial
blood gases, and assessment of diffusion capacity by the single breath
technique.
Study Design
Results were assessed according to 2 different outcome domains: 1 sur-
gical and 1 clinical.48 The Journal of Thoracic and Cardiovascular SurgeSurgical Domain
The primary outcome measure was hospital stay. For this purpose, cri-
teria for discharge were standardized. Removal of chest tubes was allowed
when daily fluid drainage was less than 200 mL and air leaks stopped. In
patients with minimal air leak and 1 chest tube remaining, a Heimlich valve
was connected to the tube, and if this proved well tolerated by the patient
and did not interfere with radiologically assessed complete lung expansion,
discharge was allowed 24 hours later provided acceptance of a 48-hour–
based outpatient clinical control program. Secondary outcome measures
included 90-day mortality, ratio of arterial oxygen tension to fraction of in-
spired oxygen (PaO2/FIO2), and arterial carbon dioxide tension (PaCO2), as-
sessed at 3 fixed time points (T1 ¼ preoperative in lateral decubitus,
T2 ¼ end operative, and T3 ¼ 1 hour after completion of the operation
and weaning).
Clinical Domain
The primary outcome measure was forced expiratory volume in 1 sec-
ond (FEV1). The secondary outcome measures were plethysmographic re-
sidual volume (RV), forced vital capacity (FVC), exercise capacity
assessed by both the 6-minute walking test (WT) and the maximal incre-
mental treadmill test, dyspnea graded according to the Modified Medical
Research Council scale, and health-related quality of life physical function-
ing domain scored according to the 36-Item Short Form questionnaire. All
clinical measures were assessed at 6 months and every 6 months thereafter.
During follow-up, the need of contralateral treatment was considered
a failure event as death. Contralateral LVRS was performed according to
strict objective criteria, including loss of benefit in FEV1 or RV back to
baseline values.
Statistics
We calculated that wewould need to enroll 30 patients per group to have
a statistical power of 80%with an alpha error of 0.05 to test the hypothesis
that compared with nonawake resectional LVRS, the awake resectional
procedure is associated with a 35% greater proportion of early discharges
(6 days). In regard to FEV1 improvement, 27 patients were calculated to
be necessary to test the hypothesis of a greater postoperative FEV1 im-
provement at 6 months in the same group according to preliminary findings
of a pilot study (DFEV1:þ0.31 vsþ0.22 L).7
Randomization was carried out centrally by means of a computer-
generated sequence of casual numbers in which treatment arms were as-
signed to paired and unpaired numbers, respectively.
Group descriptive statistics are presented as mean standard deviation
unless indicated otherwise. Two-way analysis of variance for repeated
measures was used to evaluate surgical and clinical domain outcomes. Un-
paired data were assessed stepwise by t test and Mann–Whitney test as ap-
propriate. Two-tailed Fisher exact test was used to compare proportions.
Survival and freedom from contralateral treatment were assessed by the
Kaplan–Meier method, and the log-rank test was used to match curves.
Outcome analysis was carried out on an intention-to-treat basis. Statistical
analysis was performed by Statistica software version 7.0 (StatSoft Inc,
Tulsa, Okla).
Anesthesia
Awake anesthesia. Thoracic epidural catheterization was performed
between T4 and T5 to achieve somatosensory and motor block between the
T1 and T8 level while preserving diaphragmatic motion. In the operating
room, patients received a continuous infusion of ropivacaine 0.5% and su-
fentanil 1.66 mg/mL into the epidural space. During the procedure, patients
breathed oxygen through a Venturi facemask to keep oxygen saturation
greater than 90%. Permissive hypercapnia was accepted and did not re-
quire correction unless pH decreased to less than 7.2. During wound clo-
sure, the anesthetic regimen was changed to ropivacaine 0.16% and
sufentanil 1 mg/mL at 2 to 5 mL/h.ry c January 2012
TABLE 1. Preoperative data
Awake group
Mean ± SD
Control group
Mean ± SD
Intergroup
P value
BMI 24  4 23  3 .16
FEV1 (L) 0.82  0.3 0.78  0.2 .47
FEV1 (%) 29  9 27  7 .32
FVC (L) 2.36  0.8 2.35  0.6 .94
FVC (%) 64  17 63  16 .84
RV (L) 5.05  1.0 5.29  0.7 .31
RV (%) 217  40 229  38 .24
TLC (L) 8.17  1.5 8.81  0.9 .05
TLC (%) 129  17 140  17 .03
6-minute WT (m) 300  112 329  98 .29
MITT (Bruce class) 0.58  0.3 0.65  0.4 .38
PaO2 (mm Hg) 68  8.0 67  6.0 .37
PaCO2 (mm Hg) 41  5.0 41  3.0 .69
Dyspnea index (score) 3.5  0.6 3.4  0.6 .41
PF (36-Item Short Form) 28  13 29  13 .68
BMI, Body mass index; MITT, maximal incremental treadmill test; dyspnea index,
modified Medical Research Council dyspnea score; TLC, total lung capacity; PF,
physical functioning.
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tween T5 and T8 for continuous infusion of ropivacaine, general anesthesia
was induced by intravenous propofol (1.5–2mg/kg), fentanyl (0.1 mg), and
vecuronium (0.1 mg/kg) and subsequently maintained using propofol, fen-
tanyl, and vecuronium. Intraoperative ventilatory management and 1-lung
ventilation were ensured by a left-sided double-lumen tube.
At the end of the operation (or after weaning if general anesthesia was
used), all patients were transferred to the recovery room until cardiorespi-
ratory conditions were considered stable by the anesthesiologist to allow
direct return to the ward according to a fast-track policy. In all instances,
the epidural catheter was removed 48 hours after the operation.
Surgical Technique
All surgical procedures were carried out by VATS through a 4-flexible
trocar access, with a 30-degree 10-mm camera and standard instrumenta-
tion. Independently of the type of surgical method, the aim of the operation
was to reduce the overall lung volume by approximately 20% to 30%.
Awake nonresectional lung volume reduction surgery.
Surgical pneumothorax was created by insertion of the first flexible trocar;
if lung hyperinflation persisted despite the intrapleural atmospheric pres-
sure environment, an EndoPaddle (Covidien, Norwalk, Conn) was gently
applied onto the lung to minimize lung movements during spontaneous
ventilation and improve surgical maneuvering, particularly when dealing
with pleural adhesions, which could be easily cut whenever necessary.
The most severely destroyed target areas were identified and pushed down-
ward while redundant lung edges were grasped by 2 ring forceps. Subse-
quently, both lung edges were grasped together by 1 ring forceps and
a 45-mm, non-cutting endostapler (Endopath 45NK; Ethicon Endosurgery,
Pomezia, Italy) was fired on the plicated lung region starting at the lung
apex and continuing by firing 2 other cartridges, 1 ventrally and 1 dorsally
to perform a linear, interrupted suture and reducing the lung volume by
20% to 30% (Video E1).
Nonawake resectional lung volume reduction surgery.
After insertion of the camera and careful exploration of the lung, the
most severely emphysematous lung regions were grasped by 2 ring forceps,
and staple excision of a reversed hockey stick–like single strip of lung tis-
sue was carried out to reduce the overall lung volume by 20% to 30%. In
both groups, 2 chest tubes were inserted at the end of the procedure.RESULTS
During the study period, of 87 eligible subjects, 24 pa-
tients refused randomization, whereas intraoperatively, 3
patients required conversion to general anesthesia (2 pa-
tients in the awake group) or thoracotomy (1 patient in
the control group).
The mean age in the awake and control groups was 64 
9 years and 65  7 years, respectively (P ¼ .50). Study
groups were relatively well matched in main baseline data
(Table 1).Surgical Outcome Domain
Primary outcome. Median hospital stay was 6 days (quar-
tile range [QR], 3.0 days) in the awake group and 7.5 days
(QR, 4.0 days) in the control group (P ¼ .04). Twenty-one
patients (66%) in the awake group and 10 patients (32%) in
the nonawake group were discharged within 6 days
(P ¼ .01, Figure 1). Four and 7 patients were discharged
with a Heimlich valve in the awake and control groups, re-
spectively (P ¼ .51).The Journal of Thoracic and CSecondary outcomes. Intraoperative change in oxygena-
tion variables is shown in Figure 2, which shows that
PaO2/FIO2 was reduced at T2 in both groups but returned to-
ward the preoperative value at T3 in the awake group only,
whereas it continued to deteriorate after weaning in the con-
trol group.
PaCO2 also behaved differently between the study groups.
In the awake group, a higher value of permissive hypercap-
nia developed at T2, although this rapidly decreased toward
the preoperative value at T3; in the control group, PaCO2 re-
mained at a lower level than in the awake group at T2 but
increased thereafter.
No patient in either group required intensive care unit
stay, whereas time spent in the recovery room was signifi-
cantly longer in the nonawake group (228  68 minutes
vs 93  43 minutes, P<.00001).
The nonawake group had only 1 operative mortality
(P ¼ 1.0). Nonfatal adverse events occurred in 7 patients
in the awake group (6 prolonged air leaks and 1 atrial
fibrillation) and 16 patients in the nonawake group (15 pro-
longed air leaks, 3 atrial fibrillations, and 1 pneumonia;
P ¼ .019). Three patients had more than 1 complication.
Clinical Outcome Domain
No patient was lost to follow-up.
Primary outcome. At 6 months, median DFEV1 was 0.28
L (QR: 0.16 L) in the awake (P<.00001) group versus 0.29
L (QR: 0.12 L) in the control group (P<.00001), with no
intergroup difference P ¼ .81) (Figure 1).
Secondary outcomes. Significant clinical improvements
occurred in FVC, RV, WT, maximal incremental treadmill
test, physical functioning, dyspnea index, and body mass in-
dex at 6 months. On awake versus nonawake groupardiovascular Surgery c Volume 143, Number 1 49
FIGURE 1. Outcome of primary end points in the study groups. Bar graph showing distribution of categorized hospital stay (left) and changes in FEV1 at 6
months (right).
General Thoracic Surgery Pompeo et al
G
T
Scomparisons, DFVC was 0.40  0.3 L versus 0.35  0.2 L
(P ¼ .42); DRV, 0.91  0.4 L versus 0.90  0.5 L
(P ¼ .95); Ddyspnea index,1.34  0.6 versus1.17  0.6
(P¼ .28); andDWT, 81 51m versus 85 37m (P¼ .75).
Most clinical improvements observed at 6 months lasted
for more than 2 years (Figure 3). At 24 months, 15 patients
(54%) had anDFEV1 greater than 0.1 L in the awake group
versus 17 patients (63%) in the control group (P ¼ .48). At
the 12- and 24-month assessments, significant between-
group differences were observed in body mass indexFIGURE 2. Perioperative behavior of PaO2/FIO2 (left) and PaCO2 (right) at
R1*group ¼ intergroup effect.
50 The Journal of Thoracic and Cardiovascular Surge(P < .009) and percent predicted total lung capacity
(P ¼ .03) (Table E2).
There were no differences between study arms in esti-
mated rate of freedom from contralateral treatment (55%
vs 50%, P ¼ .7) and survival (81% vs 87%, P ¼ .5) at
36 months (Figure 4). During follow-up, 12 and 14 patients
required contralateral LVRS within 36 months in the awake
and nonawake groups, respectively. Contralateral LVRS
was performed because of deterioration of FEV1 in 18 pa-
tients and of RV in 8 patients with no 90-day mortality.3 fixed time points (T1–T3). Analysis of variance: R1 ¼ overall effect;
ry c January 2012
FIGURE 3. Pre- to postoperative changes in FEV1 (left upper), FVC (mid upper), RV (right upper), 6-minute WT (left lower), body mass index (mid
lower), and dyspnea index (right lower).
FIGURE 4. Kaplan–Meier curves of estimated survival (left) and freedom from contralateral treatment (right). Patients who were alive (left) and free from
contralateral treatment (right) during follow-up are shown below each plot.
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SDISCUSSION
General anesthesia and single-lung ventilation are
deemed mandatory for LVRS, although it can be associated
with risks of pneumonia, cardiovascular and neuromuscular
adverse events, bronchospasmandairways injury, and amul-
tifactorial lung injury related to mechanical ventilation.7
Most of the aforementioned adverse effects can be
avoided by using thoracic epidural anesthesia in awake pa-
tients even though physiologic effects of such an unconven-
tional choice are still not thoroughly investigated.
In this randomized study, awake nonresectional LVRS re-
sulted in a shorter hospital stay and a significantly greater
proportion of early discharges than the control group with
significant and as yet equivalent 6-month improvements
in FEV1. Significant improvements lasting more than 2
years also occurred in secondary clinical outcomes, includ-
ing FVC, RV, WT, and subjective dyspnea with no inter-
group difference. Furthermore, no difference was detected
between study groups in survival and freedom from contra-
lateral treatment at 36 months.
Nonresectional LVRS entailing fold plication of emphy-
sematous lung regions has been anecdotally reported.9,10
Our nonresectional method has been specifically
developed by one of the authors (E.P.) to be easily and
safely performed in awake, spontaneously ventilating
patients. The method differs from the others by entailing
an introflexive plication of emphysematous lung tissue.
Although the method respects the basic concepts
advocated for resectional LVRS2 that include a reduction
of 20% to 30% of the lung volume and stapled suture along
a single ideal line, it adds some technical differences such as
peripheral suturing to minimize interruption of segmental
vessels and bronchi, an interrupted suture line, which is
more flexible to favor reexpansion of the remodeled lung,
and avoidance of discontinuation of visceral pleura with
a 4-fold pleural buttress of the suture to minimize risk of
air leaks. The validity of these theoretic advantages need
to be proved experimentally.Surgical Domain Outcome
The results of the current study showed that after awake
nonresectional LVRS, 66% of patients were discharged
within 6 days, whereas this was possible in only 32% of pa-
tients in the control group. It is difficult to discern whether
this finding is to be attributed to the avoidance of general an-
esthesia and mechanical ventilation or to the use of a nonre-
sectional method, although it is conceivable that both
components played a role. In this respect, in a recent non-
randomized study comparing nonresectional LVRS per-
formed by awake or nonawake anesthesia, median
hospital stay and overall costs were reduced in the awake
group with no intergroup difference in late clinical out-
come.8 In the current study, results of the awake group52 The Journal of Thoracic and Cardiovascular Surgecompare favorably with previous reports of unilateral
LVRS in which hospital stay ranged from 8 days4 to 17
days.11
Another issue regards our surgical strategy of unilateral
treatment followed by contralateral LVRS delayed until
benefits of the first operation are weaned. Despite the lack
of randomized studies in this setting, findings of postopera-
tive annual decay in FEV1 averaging 107 mL in unilateral
LVRS and 250 mL in bilateral LVRS3 suggest a role for
a staged unilateral approach, which is now our standard
strategy of treatment irrespective of the emphysema charac-
teristics or the type of anesthesia that is chosen.
Perioperatively, the behavior of PaO2/FIO2 differed signif-
icantly among study groups with a progressive decrease be-
tween T2 and T3 in the control group and an initial
reduction followed by a return toward the baseline value
in the awake group. In a similar manner, PaCO2 increased
to a greater extent in awake patients at T2 and returned to-
ward baseline values at T3, whereas it progressively in-
creased during time in the nonawake group. In accordance
with these findings, Buduhan and coworkers12 demon-
strated in an experimental study that there was an impair-
ment in lung mechanical properties due to decreased
respiratory compliance and increased gas trapping after
nonawake LVRS. In the clinical setting, immediately after
weaning, expiratory flow limitation hampers expiration
and worsens gas trapping, leading to rapid shallow breath-
ing that in time increases inspiratory workload, decreases
respiratory muscle capacity, and hampers carbon dioxide
elimination. Post-intubation airways irritation and accumu-
lation of secretions, expiratory muscle recruitment, and oc-
cult small airway disease secondary to increased lung water
are other factors that can increase gas trapping after nona-
wake LVRS.13 On the other hand, after awake LVRS, the
maintained diaphragmatic motion facilitates a more physi-
ologic ventilation in the early postoperative period.
Clinical Domain Outcome
At 6 months, FEV1 improved significantly in both study
groups with no intergroup difference. These results are sim-
ilar to those observed by other investigators with unilateral
and bilateral resectional LVRS.4,11,14
Overall, significant improvements in respiratory func-
tion, exercise capacity, perceived quality of life, and subjec-
tive dyspnea were observed for more than 24months in both
study groups. These findings suggest that the combination
of awake anesthesia and nonresectional LVRS did not jeop-
ardize the possibility of achieving ameaningful reduction in
lung volume and that postoperative beneficial effects did
not deteriorate in the awake group more rapidly than those
of the resectional method.
In a recent update of the National Emphysema Treatment
Trial results,15 patients with upper-lobe predominant em-
physema and low exercise capacity demonstrated improvedry c January 2012
Pompeo et al General Thoracic Surgery3-year exercise capacity, 5-year relief of dyspnea, and better
5-year survival than medically treated patients.
In the current series entailing all patients with upper-lobe
emphysema, estimated 3-year survival was greater than
80% in both study groups. So far, endoscopic procedures
proposed as an alternative to LVRS did not demonstrate
comparable efficacy.6 Thus, we confide that results of our
trial will provide further scientific data directed at accentu-
ating the positive16 role of surgery in the optimal manage-
ment of patients with emphysema.G
T
SLimitations
Limitations of this study include the small cohort with an
intergroup difference in baseline total lung capacity and the
mixed combination of 2 types of anesthesia and 2 types of
surgical methods that negated the possibility to weigh the
role of each single component in determining the final out-
comes. To attenuate these concerns, we have completed
a small, preliminary study comparing nonresectional LVRS
performed by awake or nonawake anesthesia.8 However,
we considered it unethical to perform a randomized study
comparing the results of an unconventional LVRS method
(eg, our nonresectionalLVRS technique carried out by awake
or nonawake anesthesia) because this surgical technique is
currently used by our center only, and so far there were no
other prospectively collected data confirming its reliability
when comparedwith resectional LVRS,which is still consid-
ered the gold standard by most thoracic surgeons.
We acknowledge that both the design of the trial and our
strategy entailing an intentional, initial unilateral operation
may have led to an apparent overestimation of some out-
come data because of exclusion of patients undergoing con-
tralateral treatment during time. However, we were
interested in comparing the degree of improvements in ho-
mogeneous cohorts including only patients treated in unilat-
eral fashion. Nonetheless, we have considered the need of
contralateral treatment a negative event as death, and
assessed this secondary outcome measure by the Kaplan–
Meier method, thus providing useful comparative data on
long-term outcome of all patients.CONCLUSIONS
In this randomized study, awake nonresectional LVRS
was associated with a greater proportion of early discharges
than the control group, while offering equivalent and long-
lasting clinical improvements in FEV1 and other outcome
measures. In addition, no difference was observed between
study groups in survival and need of contralateral treatment
for up to 36 months.References
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Dr BryanMeyers (St Louis, Mo). The authors have provided us
with a noteworthy trial comparing 2 alternative strategies for
LVRS in patients with advanced emphysema. The degree of im-
pairment in these patients is consistent with that seen in other re-
ports, and the amount of FEV1 improvement of approximately
37% at 6 months is certainly comparable or even better than often
seen with unilateral volume reduction surgery. So the clinical care
is to be commended. The study is prospective and randomized,
which is certainly what caught the attention of the program com-
mittee. I commend the authors on the ability to initiate and com-
plete a prospective randomized study, particularly when the 2
arms of therapy are as disparate as awake versus nonawake anes-
thetic. That’s quite a challenge, and I commend you. I do have
a few concerns that you have alreadymentioned in your limitations
that I want to underscore. The one problem I had was that the de-
sign changes 2 things as youmove from one group to the other. You
have awake and nonresection compared with nonawake and resec-
tion, and that leaves us in some doubt as we interpret the results of
the study as to which factors might contribute to the overall end re-
sult. Why did you do that? Why not alter one thing at a time andardiovascular Surgery c Volume 143, Number 1 53
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outcome?
Dr Pompeo. This is one limitation of the study that we had con-
sidered. For this reason, we had performed a small prospective
nonrandomized study comparing awake nonresectional lung vol-
ume reduction with nonawake nonresectional lung volume reduc-
tion. We recently published it in the European Journal of
Cardiothoracic Surgery, and we specifically wanted to publish it
before the presentation of this randomized study for this reason,
because we were interested in seeing if the nonresectional method
per se is sufficient to say that it can improve early results. What we
have seen is that the results were not as good as with the double
association of the nonresectional method and awake anesthesia.
This might be one answer.
Dr Meyers. Another point I would make is that you analyzed
this per protocol, that is, you chose not to use an intention-to-treat
analysis. You excluded 2 patients who could not tolerate the awake
procedure and 1 patient who was converted from the VATS ap-
proach to an open approach, and when we evaluate treatment strat-
egies, we have to compare all patients who were exposed to that
strategy and not just patients who were successfully treated with
that strategy. So I would just point that out. The final point is
that your sample size of 30 in each arm is small, although nowa-
days there aren’t a whole lot of patients needing lung volume re-
duction, and it might be small by necessity. But you justified it
by picking a primary outcome measure that I would argue is not
a clinically important factor. The fraction of patients who are dis-
charged at or before 6 days is not what I think of as the main thing
that I want to evaluate when I compare 2 strategies for LVRS. So
I’m not sure that the sample size was really sufficient to give us the
full insight into these 2 therapies.
Dr Pompeo. This is probably true. We had to choose the out-
come measure as a compromise to reach a sufficient power to per-
form the study. Obviously a larger sample size might have been
better, but it’s difficult when doing a single-center study to have
such a large quantity of patients to randomize.
Dr Meyers. I would summarize by saying this was excellent
clinical care. Both patients in both arms got a great boostwith a uni-
lateral LVRS, although my own bias would be to offer a bilateral
operation, and the conduct of the trial could have been better, but
itwas thought provoking and novel therapy on the intervention arm.
Dr Pompeo. Thank you.
Dr Scott Swanson (Boston, Mass). I enjoyed that article and am
interested in that technique. We actually published on that in the
mid-1990s. Could you give us some tips on how you actually do
it, particularly on an awake patient? Is there anything we can learn
from you about the technical part of this operation?
Dr Pompeo. There are several small tricks you can apply to op-
erate on these patients. What we have seen during time with this
kind of operation is that if the operation becomes too long, permis-
sive hypercapnia can become a problem for the patient. We have
resolved this problem in the last years by inserting a chest tube
at the beginning of the operation. In this way we can temporarily
close the trocars with fingers or gauzes and allow reexpansion of
the lung during the operation, and this has consistently reduced
the PaCO2, during the procedure. Another thing is to discuss with
the patient during the operation that difficulty in breathing can54 The Journal of Thoracic and Cardiovascular Surgebe due to the surgical pneumothorax, because the patient can
feel difficulty even though the oxygenation remains at a satisfac-
tory level. With experience you will find that the operation is
quick, simple, and safe, and I think for these patients, avoiding
general anesthesia is a big advance.
Dr J. Shrager. Scott, is this technique exactly what you de-
scribed when you reported it? I seem to recall that you do some
sort of twisting of the parenchyma that is a bit different than this?
Dr Swanson. I’m not quite sure. Yes, wewere folding along and
then stapling.
Dr Pompeo. But there is a difference between the techniques.
Dr Swanson proposed a folding technique, repeatedly folding on
the lung surface, whereas we perform a single introflexing plica-
tion.We push the lung down inside the underlying tissue and suture
it above, along a single ideal line, as with the resectional technique.
Dr Shrager. Sort of like plicating a diaphragm. Is that what
you’re trying to describe?
Dr Pompeo. Yes, something like that.
Dr Swanson. I have just one follow-up question. Were you able
to dealwith adhesions through this technique, orwas that a problem?
Dr Pompeo. Sorry?
Dr Swanson.Did you run into any adhesions in the chest during
the awake cases, and if so, can you handle adhesions to the chest
wall with this technique?
Dr Pompeo. Well, regarding adhesions, it’s not really a prob-
lem. We normally use an EndoPaddle to push on the lung and
see the apical parts of the lung better to cut the adhesions. It
may require some more time than with a resectional technique,
but it’s quite simple as well.
Dr Walter Weder (Zurich, Switzerland). Congratulations on
your work. I have 2 questions. Why did you offer all these patients
a unilateral and not a bilateral volume reduction?
Dr Pompeo. We actually offered a staged bilateral procedure.
What we do is initially perform a unilateral procedure. As you
probably know, we are convinced that a staged bilateral procedure
is better than a 1-stage bilateral procedure. Some studies have
demonstrated that after a 1-stage bilateral procedure, the decay
in FEV1 is approximately 250 mL/year, whereas after a unilateral
procedure, the decay is approximately 107 mL/year, and we be-
lieve this is a good reason to do a staged procedure if the patient
can improve significantly with a unilateral lung volume reduction.
DrWeder. In your Abstract you stated that the improvement of
FEV1 lasted for 3 years, and in your presentation you said it was
statistically improved for 2 years. You excluded all patients who
had failures and needed a second operation. Do you think it is cor-
rect to exclude the worst cases for evaluating the long-term effect?
Dr Pompeo. This is an important question. Our aim was not to
demonstrate that lung volume reduction is capable of improving
pulmonary function. We know that this is possible, and I think
there are already enough data to demonstrate this. What we were
interested in was to compare the results between the awake and
nonawake procedures. I know that in this way, by excluding pa-
tients who were operated contralaterally, we have created a bias,
but the bias is unavoidable, because otherwise we had to consider
all the patients, and we had some patients operated unilaterally and
some bilaterally. We would prefer to show the results of the bilat-
eral procedures later.ry c January 2012
TABLE E1. Inclusion and exclusion criteria adopted for the trial
Inclusion criteria
Severe smoking-related emphysema with upper-lobe predominance
Severe disability despite maximized medical therapy including respiratory rehabilitation with Modified Medical Research Council dyspnea grade  3
No clinically significant sputum production, bronchiectasis, or asthma
Post-bronchodilator FEV1  40% predicted
Plethysmographic RV  180% predicted with TLC>120% predicted
Peak systolic pulmonary artery pressure<50 mm Hg on color Doppler echocardiography
Arterial carbon dioxide<50 mm Hg
Diffusion capacity of carbon monoxide>20% predicted
Quit smoking for at least 4 mo
Age  80 y
ASA score  3
Body mass index>18<29.
No instable angina or ventricular arrhythmia
No comorbid condition that would significantly increase operative risk or negatively affect participation in a vigorous respiratory rehabilitation program
No neoplastic disease with life expectancy<12 mo
No previous pleurodesis or thoracotomy in the hemithorax targeted for LVRS
Exclusion criteria
Radiologic evidence of extensive pleural adhesions or previous thoracotomy in hemithorax targeted for LVRS
Patient refusal or noncompliance to thoracic epidural anesthesia and awake surgery
Patient refusal or noncompliance to general anesthesia and 1-lung ventilation
Unfavorable anatomy for thoracic epidural anesthesia
Previous surgery of the cervical or upper thoracic spine
Compromised coagulation with thromboplastin time<80%, prothrombin time>40 sec, platelet count<100/nL, or bleeding disorder
TLC, Total lung capacity; ASA, American Society of Anesthesiology; BMI, body mass index.
TABLE E2. Clinical results in the study groups
Baseline 6 mo 12 mo 24 mo
Awake Control Awake Control Awake Control Awake Control
BMI 24  4 23  3 24  3 23  3y 25  2y 24  2y 26  2y 24  2y
FEV1 (L) 0.82  0.3 0.78  0.2 1.11  0.3* 1.06  0.2* 1.11  0.2* 1.07  0.2* 1.02  0.2* 0.99  0.2*
FEV1 (%) 29  9 27  7 40  10* 37  9* 40  9* 37  9* 36  9* 34  8*
FVC (L) 2.36  0.8 2.35  0.5 2.87  0.6* 2.72  0.6* 2.84  0.6* 2.80  0.5* 2.73  0.6* 2.76  0.5*
FVC (%) 64  17 63  16 78  13* 74  17* 78  13* 76  16* 73  13* 75  13*
RV (L) 5.05  1.0 5.29  0.7 4.0  0.8* 4.37  0.6* 4.07  0.9* 4.46  0.6* 4.29  0.7* 4.69  0.6*
RV (%) 217  40 229  38 171  29* 188  34* 174  34* 194  37* 181  28* 201  36*
TLC (L) 8.17  1.5 8.81  0.9 7.43  1.5* 8.15  0.8* 7.40  1.5* 8.21  0.8* 7.50  1.5* 8.38  0.7*
TLC (%) 129  17 140  17 117  17* 129  13* 117  17* 130  14* 119  16* 132  14*
6-min WT (m) 300  112 329  98 392  114* 418  74* 403  78* 432  79* 391  83* 418  74*
MITT (Bruce class) 0.58  0.3 0.65  0.4 1.53  0.7* 1.54  0.7* 1.73  0.6* 1.82  0.6* 1.60  0.6* 1.66  0.6*
PAO2 (mm Hg) 68  8.0 67  6.0 72  9.0* 70  6.0* 71  9.0y 70  5.0* 69  9.0 68  6.0
PaCO2 (mm Hg) 41  5.0 41  3.0 39  3.0z 40  3.3z 39  3.0 40  2.0z 41  4.0 41  3.0
Dyspnea index (score) 3.5  0.6 3.4  0.6 2.14  0.7* 2.21  0.7* 2.00  0.6* 2.12  0.6* 2.26  0.8* 2.19  0.6*
PF (36-Item Short Form score) 28  13 29  13 59  17* 51  17* 59  16* 52  17* 54  11* 53  15*
BMI, Body mass index; MITT, maximal incremental treadmill test; dyspnea index, modified Medical Research Council dyspnea score; TLC, total lung capacity; PF, physical
functioning. Within-group *P<.00009, yP<.002, zP<.03. Data reported as mean  SD.
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